• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Intertek banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

US Senate votes down bill that would have banned enforcement of the CFC inhaler phaseout

US Senator Jim DeMint, a Republican from South Carolina, failed to persuade the US Senate to prohibit the use of tax dollars for enforcement of the FDA ban on the CFC-propelled OTC epinephrine inhaler Primatene Mist. The Senate voted 54-44 against DeMint’s bill.

DeMint expressed outrage at the outcome of the vote: “Fifty-four Senators voted to appease extreme environmentalists by banning inhalers that millions of Americans that depend on to breathe. This ban won’t do anything serious to help the environment but it will force asthma suffers to spend two to three times more on prescription inhalers, leading many low-income Americans to seek less effective remedies. Even the EPA and FDA admit that banning OTC inhalers will do little to nothing to affect the ozone, but it could lead to hundreds of thousands of new asthma related hospital visits and hundreds of millions in new health costs.”

“This is exactly the kind of ridiculous regulation that shows why Americans are so fed up with the federal government’s nanny-state mentality,” he continued. “Once again, Washington is willing to put Americans at risk in the hopes of appeasing special interests.”

During the debate prior to the vote, Democratic Senator Barbara Boxer of California said, “This amendment affects the ability of people with asthma to purchase an inhaler that works, and the American Lung Association opposes this amendment. The American Thoracic Society, which is the expert–these are the experts on anything to do with respiratory diseases. There are 150,000 doctors who oppose this amendment.”

“I am perplexed by it because the reason we want to get away from these CFCs is because Ronald Reagan signed the treaty to do away with them and George W. Bush passed the rule to do away with them. On behalf of the people who depend on inhalers that work right, that don’t use CFCs, I hope we will stand with the Lung Association and the 150,000 doctors of the Thoracic Society. I hope we will vote this down.”

DeMint responded, “Certainly, there are many doctors who want folks to come in and get prescriptions. There are many manufacturers who make prescription drugs, but let 3 million Americans access these inhalers. They do not cause any problems with the environment. The EPA has recognized it is negligible and the manufacturer will have this worked out over the next few years.”

The FDA has been attempting to prepare Primatene Mist users for the phase-out, which takes effect after December 31, 2011.

Read Senator DeMint’s press release.

Share

published on November 2, 2011

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews